Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 11/20 | 0.54 |
| ▸ | NPY1R | P25929 | 6/20 | 0.54 |
| ▸ | NPY2R | P49146 | 4/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.54 |
| ▸ | FNTA | P49354 | 3/20 | 0.48 |
| ▸ | FNTB | P49356 | 3/20 | 0.48 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.48 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6471903 | 1.00 | NPY4R (0.54) | NPY4RNPY1RNPY2RNPY5RFNTA | |
| SCHEMBL30272466 | 0.92 | FNTA (0.55) | NPY4RNPY1RNPY2RNPY5RFNTA | |
| SCHEMBL6470789 | 0.90 | NPY4R (0.57) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL6470804 | 0.90 | NPY4R (0.57) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL6473554 | 0.89 | NPY4R (0.68) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL6472571 | 0.89 | NPY4R (0.68) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL6472563 | 0.89 | NPY4R (0.68) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL6473543 | 0.89 | NPY4R (0.68) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30045696 | 0.87 | FNTA (0.59) | NPY4RNPY1RNPY2RNPY5RFNTA | |
| SCHEMBL6472534 | 0.87 | NPY4R (0.64) | NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005040802-A2 | CYLIN BINDING PEPTIDES, AND THEIR USE IN DRUG SCREENING ASSAYS | CYCLACEL LIMITED (GB) | 2005-05-06 | — | — | WO | disclosed |
| EP-1250353-A2 | P21 DERIVED PEPTIDES CAPABLE OF INHIBITING CDK/CYCLIN COMPLEXES | Cyclacel Limited (GB) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001040142-A2 | P21 DERIVED PEPTIDES CAPABLE OF INHIBITING CDK/CYCLIN COMPLEXES | CYCLACEL LIMITED (GB) | 2001-06-07 | — | — | WO | disclosed |